Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 69.85
+3.75 (5.67%)
Oct 31, 2025, 4:08 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 37.96 billion as of October 31, 2025. Its market cap has increased by 209.07% in one year.
Market Cap
37.96B
Enterprise Value
40.92B
Revenue
6.35B
Ranking
n/a
PE Ratio
42.03
Stock Price
69.85
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 37.96B, an increase of 42.40%. That is a compound annual growth rate of 5.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 37.96B | 194.73% |
| Dec 31, 2024 | 12.88B | 70.50% |
| Dec 29, 2023 | 7.55B | 8.59% |
| Dec 30, 2022 | 6.96B | -41.95% |
| Dec 31, 2021 | 11.98B | -53.04% |
| Dec 31, 2020 | 25.52B | 15.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 263.63B |
| Hansoh Pharmaceutical Group Company | 207.05B |
| JD Health International | 194.33B |
| WuXi Biologics | 148.69B |
| Innovent Biologics | 138.28B |
| Sino Biopharmaceutical | 122.81B |
| Akeso | 104.46B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.31B |